191 related articles for article (PubMed ID: 33185887)
1. A simple echocardiographic score to rule out cardiac amyloidosis.
Aimo A; Chubuchny V; Vergaro G; Barison A; Nicol M; Cohen-Solal A; Castiglione V; Spini V; Giannoni A; Petersen C; Taddei C; Pasanisi E; Chacko L; Martone R; Knight D; Brown J; Martinez-Naharro A; Passino C; Fontana M; Emdin M
Eur J Clin Invest; 2021 May; 51(5):e13449. PubMed ID: 33185887
[TBL] [Abstract][Full Text] [Related]
2. Cardiac "hypertrophy" phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography.
Ferkh A; Tjahjadi C; Stefani L; Geenty P; Byth K; De Silva K; Boyd AC; Richards D; Mollee P; Korczyk D; Taylor MS; Kwok F; Kizana E; Ng ACT; Thomas L
Front Cardiovasc Med; 2023; 10():1183485. PubMed ID: 37465456
[TBL] [Abstract][Full Text] [Related]
3. A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.
Zhang KW; Zhang R; Deych E; Stockerl-Goldstein KE; Gorcsan J; Lenihan DJ
Am Heart J; 2021 Feb; 232():137-145. PubMed ID: 33212046
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography.
Zhang L; Zhou X; Wang J; Mu Y; Liu B; Lv W; Wang Y; Liu H; Liu H; Zhi G
Int J Cardiovasc Imaging; 2017 Apr; 33(4):499-507. PubMed ID: 27878699
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study.
Schiano-Lomoriello V; Galderisi M; Mele D; Esposito R; Cerciello G; Buonauro A; Della Pepa R; Picardi M; Catalano L; Trimarco B; Pane F
Echocardiography; 2016 Sep; 33(9):1335-43. PubMed ID: 27277827
[TBL] [Abstract][Full Text] [Related]
6. Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.
Rausch K; Scalia GM; Sato K; Edwards N; Lam AK; Platts DG; Chan J
Int J Cardiovasc Imaging; 2021 Jan; 37(1):81-90. PubMed ID: 32728989
[TBL] [Abstract][Full Text] [Related]
7. External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis.
Monda E; Palmiero G; Lioncino M; Rubino M; Caiazza M; Dongiglio F; Limongelli G
Int J Cardiol; 2021 Sep; 339():99-101. PubMed ID: 34289405
[TBL] [Abstract][Full Text] [Related]
8. Comparison of echocardiographic parameters in Fabry cardiomyopathy and light-chain cardiac amyloidosis.
Marek J; Palecek T; Magne J; Lavergne D; Boulogne C; Fadel BM; Jaccard A; Linhart A; Mohty D
Echocardiography; 2018 Nov; 35(11):1755-1763. PubMed ID: 30247786
[TBL] [Abstract][Full Text] [Related]
9. Right ventricular longitudinal strain: a tool for diagnosis and prognosis in light-chain amyloidosis.
Uzan C; Lairez O; Raud-Raynier P; Garcia R; Degand B; Christiaens LP; Rehman MB
Amyloid; 2018 Mar; 25(1):18-25. PubMed ID: 29260587
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis.
Boldrini M; Cappelli F; Chacko L; Restrepo-Cordoba MA; Lopez-Sainz A; Giannoni A; Aimo A; Baggiano A; Martinez-Naharro A; Whelan C; Quarta C; Passino C; Castiglione V; Chubuchnyi V; Spini V; Taddei C; Vergaro G; Petrie A; Ruiz-Guerrero L; Moñivas V; Mingo-Santos S; Mirelis JG; Dominguez F; Gonzalez-Lopez E; Perlini S; Pontone G; Gillmore J; Hawkins PN; Garcia-Pavia P; Emdin M; Fontana M
JACC Cardiovasc Imaging; 2020 Apr; 13(4):909-920. PubMed ID: 31864973
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
[TBL] [Abstract][Full Text] [Related]
12. Cardiac amyloidosis without increased left ventricular wall thickness.
Lee GY; Kim K; Choi JO; Kim SJ; Kim JS; Choe YH; Grogan MA; Jeon ES
Mayo Clin Proc; 2014 Jun; 89(6):781-9. PubMed ID: 24702732
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis.
Cariou E; Bennani Smires Y; Victor G; Robin G; Ribes D; Pascal P; Petermann A; Fournier P; Faguer S; Roncalli J; Rousseau H; Chauveau D; Carrié D; Berry I; Galinier M; Lairez O;
Amyloid; 2017 Jun; 24(2):101-109. PubMed ID: 28553897
[TBL] [Abstract][Full Text] [Related]
14. Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters.
Pagourelias ED; Mirea O; Duchenne J; Van Cleemput J; Delforge M; Bogaert J; Kuznetsova T; Voigt JU
Circ Cardiovasc Imaging; 2017 Mar; 10(3):e005588. PubMed ID: 28298286
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
16. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis.
Pozo E; Kanwar A; Deochand R; Castellano JM; Naib T; Pazos-López P; Osman K; Cham M; Narula J; Fuster V; Sanz J
Heart; 2014 Nov; 100(21):1688-95. PubMed ID: 25012950
[TBL] [Abstract][Full Text] [Related]
17. Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis.
Aimo A; Fabiani I; Giannoni A; Mandoli GE; Pastore MC; Vergaro G; Spini V; Chubuchny V; Pasanisi EM; Petersen C; Poggianti E; Taddei C; Castiglione V; Latrofa S; Panichella G; Sciaccaluga C; Georgiopoulos G; Passino C; Cameli M; Emdin M
Eur Heart J Cardiovasc Imaging; 2022 Dec; 24(1):130-141. PubMed ID: 35292807
[TBL] [Abstract][Full Text] [Related]
18. Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure.
Löfbacka V; Suhr OB; Pilebro B; Wixner J; Sundström T; Lindmark K; Anan I; Lindqvist P
Clin Physiol Funct Imaging; 2021 Sep; 41(5):408-416. PubMed ID: 34033209
[TBL] [Abstract][Full Text] [Related]
19. The Role of Standard Echocardiographic Parameters in Endomyocardial Biopsy Proven Cardiac Amyloidosis.
Biočić S; Jurinjak SJ; Vincelj J; Barić D; Manojlović S; Brkljačić DD
Coll Antropol; 2015 Jun; 39(2):441-5. PubMed ID: 26753463
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of left ventricular rotational mechanics in patients with systemic amyloidosis, systemic hypertension and normal left ventricular mass.
Cappelli F; Porciani MC; Bergesio F; Perfetto F; De Antoniis F; Cania A; Tronconi F; Ricceri I; Padeletti L
Clin Physiol Funct Imaging; 2011 Mar; 31(2):159-65. PubMed ID: 21310001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
